Kaiyuan Deng
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Targeting the FBXW7-AKAP13-YAP axis suppresses gliomagenesis by dual inhibition of tumor invasion and macrophage recruitment.
Journal: Biochemical pharmacology
Published: September 25, 2025
Tumor DNA from tumor in situ fluid was used to track evolution of glioma under first-line treatment.
Tumor DNA from tumor in situ fluid was used to track evolution of glioma under first-line treatment.
Journal: Frontiers in oncology
Published: February 21, 2025
Dynamic Monitoring of Circulating Tumor DNA to Predict the Risk of Non In Situ Recurrence of Postoperative Glioma: A Prospective Cohort Study.
Journal: Cancer medicine
Published: March 16, 2024
Genomic alterations of oligodendrogliomas at distant recurrence.
Journal: Cancer medicine
Published: January 18, 2023
Molecular and clonal evolution in vivo reveal a common pathway of distant relapse gliomas.
Journal: iScience
Published: October 06, 2022
Real-time longitudinal analysis of human gliomas reveals in vivo genome evolution and therapeutic impact under standardized treatment.
Journal: Clinical and translational medicine
Published: April 02, 2022
Tumor DNA From Tumor In Situ Fluid Reveals Mutation Landscape of Minimal Residual Disease After Glioma Surgery and Risk of Early Recurrence.
Journal: Frontiers in oncology
Published: July 15, 2021
Integrating real-time in vivo tumour genomes for longitudinal analysis and management of glioma recurrence.
Journal: Clinical and translational medicine
Published: June 21, 2021
Characterizing the Genomic Landscape of Brain Glioma With Circulating Tumor DNA From Tumor In Situ Fluid.
Journal: Frontiers in oncology
Published: July 24, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026